Experimentation under beam

Influence of radiolysis on astatine-211 chemistry
Ghalei M, Khoshouei PM, Vandenborre J, Guérard F, Blain G, Zarei M, Haddad F, Fattahi M (P-169)
iSRS 2022 (24th international Symposium of Radiopharmaceuticals Sciences), Nantes, France, May 29 – June 2, 2022

Reduced toxicity of alpha particles at Ultra-High Dose Rate in Zebrafish empryos
Y. Ghannam, G. Saade, S. Chiavassa, C. Koumeir, G. Blain, M. Evin, Q. Mouchard, F. Haddad, L. Maigne, N. Servagent, G. Delpon, S. Supiot, V. Potiron
2nd Flash Radiotherapy and Particle Therapy Conference, 30 November-2 Décember 2022, Barcelona, Spain

Reduction of Radiotoxcicity by Ultra-High Dose Rate Protontherapy
G. Saade E. Bogaerts, S. Chiavassa, G. Blain, G. Delpon, M. Evin, Y. Ghannam, F. Haddad, K. Haustermans, C. Koumeir, E. Mavaeva, L. Maigne, Q. Mouchard, N. Servagent, E. Sterpin, S. Supiot, V. Potiron.
2nd Flash Radiotherapy and Particle Therapy Conference, 30 November-2 Décember 2022, Barcelona, Spain
hal-03886326

Upgrade of the FLASH beam monitoring system at ARRONAX Cyclotron
Q. Mouchard, N. Servagent, C. Koumeir, G. Blain, A. Bongrand, S. Chiavassa, S. Deffet, G. Delpon, M. Evin, A. Guertin, R. Lubarbe, S. Lucas, V. Métivier, F. Poirier, V. Potiron, F. Ralite, S. Rossomme, L. Schoenauen, E. Sterpin, F. Haddad
2nd Flash Radiotherapy and Particle Therapy Conference, 30 November-2 Décember 2022, Barcelona, Spain
hal-03885576